Epidermodysplasia verruciformis human papillomaviruses in skin cancer and psoriasis;Wirusy brodawczaka swoiste dla epidermodysplasia verruciformis w rakach skóry i łuszczycy

Przeglad Dermatologiczny

Volumn 90, Issue 5, 2003, Pages 327-333

  Majewski, Sławomir ^a   Jabłońska, Stefania ^b  

^a AM   (Poland)

^b Klinika Dermatologiczna Medical University of Warsaw   (Poland)

Author keywords

Epidermodysplasia verruciformis; Human papillomaviruses; Psoriasis; Skin cancer

Indexed keywords

ONCOPROTEIN; PROTEIN ANTIBODY; VIRUS DNA; VIRUS PROTEIN;

ANTIBODY SPECIFICITY; AUTOIMMUNITY; BURN; CELL INTERACTION; CELL PROLIFERATION; CELLULAR IMMUNITY; DNA DETERMINATION; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER1 GENE; EVER2 GENE; GENE; GENE MUTATION; HAIR FOLLICLE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOPATHOLOGY; KERATINOCYTE; LYMPHOCYTE; NONHUMAN; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; PSORIASIS; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; VIROGENESIS; VIRUS CAPSID; WART VIRUS;

EID: 0242571987     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Majewski S., Jabłońska S.: Epidermodysplasia verruciformis i genetyczne raki zwia̧zane z zakazėniem wirusem brodawczaka i swoista̧ immunotolerancja̧. Przegl Dermatol 1998, 85, 235-244.
2. Jablońska S., Da̧browski J., Jakubowicz K.: Epidermodysplasia verruciformis as a model in studies on the role of papovavirus in oncogenesis. Cancer Res 1972, 32, 585-589.
3. Jabłońska S., Orth G., Obalek S. i inni: Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: a counterpart of Shope papilloma-carcinoma complex. Arch Geschwulstforsch 1983, 53, 207-215.
4. Orth G., Jabłońska S., Favre M. i inni: Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci USA 1978, 75, 1537-1541.
5. Orth G., Jabłońska S., Jarza̧bek-Chorzelska M. i inni: Characteristic of the lesions and risk of malignant conversion association with the type human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 1979, 39, 1074-1082.
6. Han R., Breitburd F., Marche P.N. i inni: Analysis of the nucleolide sequence variation of the antigen-binding domain of DRα and DQα molecules as related to the evaluation of papillomavirus-induced warts in rabbits. J Invest Dermatol 1994, 103, 376-380.
7. Breitburd F., Coursaget P.: Human papillomavirus vaccines. Cancer Biol 2000, 9, 431-445.
8. Ramoz N., Rueda L.A., Bouadjar B. i inni: Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nature Genet 2002, 32, 579-581.
9. Obalek S., Favre M., Szymańczyk J. i inni: Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV 3-related types in immunosuppressed patients. J Invest Dermatol 1992, 98, 936-941.
10. Prose N.S., von Knebel-Doeberitz C., Miller S. i inni: Widespread flat warts associated with human papillomavirus type 5: A cutaneous manifestation of human immunodeficiency virus infection. J Am Acad Dermatol 1990, 23, 978-981.
11. Jabłońska S., Majewski S.: Epidermodysplasia verruciformis: Immunological and clinical aspects. [w:] Curr Top Microbiol Immunol, zur Hausen H. (red.), Springer-Verlag, Berlin 1994, 186, 158-175.
12. th International Papillomavirus Conference, Paris, Institut Pasteur, October 4-9, 2002, Book of Abstracts 2002, 206.
13. Pfister H., Schegget J.: Role of HPV in cutaneous premalignant and malignant tumors. Clinics Dermatology 1997, 15, 335-348.
14. Harwood C.A, Proby Ch.M.: Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002, 15, 101-114.
15. Berkhout R.J.M., Tieben L.M., Smits H.L. i inni: Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995, 33, 690-695.
16. De Jong-Tieben L.M., Berkhout R.J.M., Smiths H.I. i inni: High frequency of detection of epidermodysplasia verruciformisassociated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995, 105, 367-371.
17. Harwood C.A., Spink P.J., Surentheran T. i inni: Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999, 37, 3545-3555.
18. De Jong-Tieben L.M., Berkhout R.J., Schegget J. i inni: The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000, 69, 44-49.
19. Berkhout R.J., Bouwes Bavinck J.N., Schegget J.: Persistence of human papillomavirus DNA in benign and premalignant skin lesions from renal transplant recipients. J Clin Microbiol 2000, 38, 2087-2096.
20. Surentheran T., Harwood C.A., Spink P.J. i inni: Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach. J Clin Pathol 1998, 51, 606-610.
21. Meyer T., Arndt R., Christophers E. i inni: Frequency and spectrum of HPV types detected in cutaneous squamous-cell carcinomas depend on the HPV detection system: a comparison of four PCR assays. Dermatology 2000, 201, 204-211.
22. De Villiers E.M., Lavargne D., McLaren K. i inni: Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997, 73, 358-361.
23. Harwood C.A., Surentheran T., McGregor J.M. i inni: Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000, 61, 289-297.
24. Majewski S., Jabłońska S.: Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002, 138, 649-654.
25. De Villiers E.M.: Human papillomavirus infections in skin cancers. Biomed Pharmacother 1998, 52, 26-33.
26. Wieland U., Ritzkowsky A., Stoltidis M. i inni: Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000, 115, 124-128.
27. Jackson S., Storey A.: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UVA damage. Oncogene 2000, 19, 592-598.
28. Padlewska K., Ramoz N., Cassonnet P. i inni: Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J Invest Dermatol 2001, 117, 935-942.
29. Astori G., Lavergne D., Benton C. i inni: Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998, 110, 752-755.
30. Boxman I.L., Berkhout R.J., Mulder L.H. i inni: Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997, 108, 712-715.
31. Boxman I.L., Russell A., Mulder L.H.C. i inni: a. case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer 2000, 86, 118-121.
32. Antonsson A., Forslund O., Ekberg H. i inni: The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000, 74, 11636-11641.
33. Orth G., Favre M., Majewski S. i inni: Epidermodysplasia verruciformis defines a subset of cutaneous papillomaviruses. J Virol 2001, 75, 4952-4953.
34. Favre M., Majewski S., Noszczyk B. i inni: Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 2000, 114, 403-407.
35. Favre M., Orth G., Majewski S. i inni: Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998, 110, 311-317.
36. Deau M.C., Favre M., Orth G.: Genetic heterogeneity among papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 1991, 184, 492-503.
37. Weissenborn S.J., Hopfl R., Weber F. i inni: High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol 1999, 113, 122-126.
38. th International Papillomavirus Conference, Paris, Institut Pasteur, October 4-9, 2002, Book of Abstracts, 66.
39. th International Papillomavirus Conference, Institut Pasteur, Paris, October 4-9, 2002, Book of Abstracts, 112.
40. Ramoz N., Rueda L.A., Bouadjar B. i inni: A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999, 112, 259-263.
41. Ramoz N., Taieb A., Rueda L.A. i inni: Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000, 114, 1148-1153.
42. Wrone-Smith T., Nickoloff B.J.: Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996, 98, 1878-1887.
43. Nickoloff B.J., Wrone-Smith T.: Superantigens, autoantigens, and pathogenic T cells in psoriasis. J Invest Dermatol 1998, 110, 459-460.
44. Chang J.C.C., Smith L.R., Froning K.J. i inni: CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/or Vβ13.1 genes. Proc Natl Acad Sci USA 1994, 91, 9282-9286.
45. Chang J.C.C., Smith L.R., Froning K.J. i inni: Persistence of T-cell clones in psoriatic lesions. Arch Dermatol 1997, 133, 703-708.
46. Bour H., Puisieux I., Even J. i inni: T-cell repertoire analysis in chronic plaque psoriasis suggests an antigen-specific immune response. Human Immunol 1999, 60, 665-676
47. Beutner E.H., Jabłońska S., Hebborn P. i inni: Autoimmunity in psoriasis. [w:] Immunopathology of the Skin. 3 ed. E.H. Beutner, T.P. Chorzelski, V. Kumar (red.). John Wiley, New York, 1987, 703-726.
48. Jab́ońska S., Chowaniec O., Beutner E.H. i inni: Stripping of the stratum corneum in patients with psoriasis. Arch Dermatol 1982, 118, 652-657.
49. Nickoloff B.J., von den Driesch P., Raychaudhuri S.P. i inni: Is psoriasis a T-cell disease? Exp Dermatol 2000, 9, 359-375.
50. Harwood C.A., Spink P. J., Surentheran T. i inni: Epidermodysplasia verruciformis-type human papillomaviruses in PUVA-associated non-melanoma skin cancers. Br J Dermatol 1997, 136, 445.